Replies to post #950 on Calypte Biomedical Corp (fka CBMC)

[coinstarz]

I concur. Sometimes CEO's big mouth does harm the stock. I am not so sure if Calypte needs priority review after SFDA accepted the package. If SFDA can keep 35 working day (5 working a week) pace, we should get something this month. But we never know what the political issue going to come out with HIV.

I listened the CC. Gale didn't know too much about how SFDA works. He thought SFDA is the same as US FDA. I guess Marr group handles the case in China. Roger Gale has to keep his lip tight before AMEX hearing.

By the way, Level II 0.19 seems strong for several days but we never know until it happens....